NSE · AI Signal & Stock Analysis · Bearish
As of Nov 13 2026, 6:15 AM, AkshayaAI's signal for SUNPHARMA is Bearish ↓ (moderate move); technical trend raise-2026-11-05; trading at ₹1,885.00 (-0.91% today); neutral (RSI 67). What changed: the technical trend turned Raise (was down-trend) on 5 Nov 2026.
Data as of Nov 13 2026, 6:15 AM. Informational analytics only — not investment advice.
Instant, data-backed answers — free to try.
| AI signal | Bearish ↓ · Moderate move |
|---|---|
| Technical trend | RAISE-2026-11-05 |
| Price | ₹1,885.00 |
| Change today | -0.91% |
| RSI (14) | 66.90 |
| Relative volume | 1.26 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | ₹4.51 Lakh Cr |
| P/E | 41.14 |
| Cap category | Mega Cap |
| 52-week high | -5.8% away |
| 52-week low | +19.7% above |
| Delivery volume | — |
| Sector | Drug Manufacturers - Specialty & Generic |
As of Nov 13 2026, 6:15 AM, AkshayaAI's signal for SUNPHARMA (Sun Pharmaceutical Industries Limited) is Bearish with a moderate move, and its technical trend is raise-2026-11-05. The composite score and full factor breakdown are available to signed-in members.
SUNPHARMA's RSI is neutral (RSI 67). A reading above 70 is typically overbought and below 30 oversold.
SUNPHARMA is trading about 6% below its 52-week high and 20% above its 52-week low as of Nov 13 2026, 6:15 AM.
SUNPHARMA's market capitalisation is ₹4.51 Lakh Cr as of Nov 13 2026, 6:15 AM.
SUNPHARMA is classified under Drug Manufacturers - Specialty & Generic in AkshayaAI's taxonomy.
AkshayaAI refreshes its signals daily. The figures on this page are timestamped as of the latest run shown above.
No. AkshayaAI provides informational, AI-generated analytics for SUNPHARMA — not personalised investment advice. Always do your own research.
AARTIPHARM · ABBOTINDIA · AJANTPHARM · AKUMS · ALIVUS · ALKEM
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Nov 13 2026, 6:15 AM and may not reflect real-time prices. Always do your own research. How these signals work →